Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tor

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Medicina Clinica|April 7, 1984
[Enterobacter agglomerans bacteremia (Erwinia herbicola)]A Guarga, A Urrutia, R Muga, et al.
Medicina Clinica|October 12, 1991
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]V Soriano, I Hewlett, J Tor, et al.
Neurology|November 1, 1988
Asymptomatic HIVB Clotet, J Romeu, V Soriano, et al.
Medicina Clinica|January 25, 1986
[Changes in cellular immunity in parenteral drug addicts]J Tor, J Juncá, R Muga, et al.
Medicina Clinica|November 10, 1981
[Giant cell arteritis and fever of unknown origin (author's transl)]J Villalta, J Vilaseca, M Ingelmo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 2, 2000
An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamateJ F Bowyer, G D Newport, W Slikker, et al.
Journal of Epidemiology and Community Health|March 18, 2004
Impact of injecting drug use on the interruption of antiretroviral therapiesR Muga, J M Egea, A Sanvisens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug useR Muga, J Roca, J M Egea, et al.
Medicina Clinica|January 27, 1996
[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset]J M Egea, J Tor, R Muga, et al.
Epidemiology and Infection|February 27, 2009
Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusersI Rivas, I Latorre, A Sanvisens, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Medicina Clinica|April 7, 1984
[Enterobacter agglomerans bacteremia (Erwinia herbicola)]A Guarga, A Urrutia, R Muga, et al.
Medicina Clinica|October 12, 1991
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]V Soriano, I Hewlett, J Tor, et al.
Neurology|November 1, 1988
Asymptomatic HIVB Clotet, J Romeu, V Soriano, et al.
Medicina Clinica|January 25, 1986
[Changes in cellular immunity in parenteral drug addicts]J Tor, J Juncá, R Muga, et al.
Medicina Clinica|November 10, 1981
[Giant cell arteritis and fever of unknown origin (author's transl)]J Villalta, J Vilaseca, M Ingelmo, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 2, 2000
An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamateJ F Bowyer, G D Newport, W Slikker, et al.
Journal of Epidemiology and Community Health|March 18, 2004
Impact of injecting drug use on the interruption of antiretroviral therapiesR Muga, J M Egea, A Sanvisens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug useR Muga, J Roca, J M Egea, et al.
Medicina Clinica|January 27, 1996
[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset]J M Egea, J Tor, R Muga, et al.
Epidemiology and Infection|February 27, 2009
Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusersI Rivas, I Latorre, A Sanvisens, et al.
Pageof 16